MAPT and Alzheimer disease: Ac-K311 appeared as 3R-specific in soluble tau, as it was observed in AD (60%), FTLD-3R (83%), and PiD (80%) subjects, but not in any case with CBD or FTLD-4R (Fig. 5a–right).